US proposes to skip inspection of firms audited by a GHTF member
This article was originally published in RAJ Devices
Device manufacturers whose establishments have been audited under one of the regulatory systems of a founding member of the Global Harmonization Task Force might be able to avoid undergoing a re-inspection by the US Food and Drug Administration for a period of one year1,2.
You may also be interested in...
Days after a senior Chinese government official offered free COVID-19 vaccines to the Philippines government, the country’s medicines regulator said the donated jabs would need an emergency approval before they can be used on the public.
The European Directorate for the Quality of Medicines & HealthCare is proceeding carefully to find the right balance between serving the diverse requirements of various stakeholders that make use of its ‘certificates of suitability.’
The International Pharmaceutical Regulators Programme has documented various approaches currently being used for the clinical comparability of biosimilar monoclonal antibodies in different jurisdictions.